Hematologic Neoplasms

"Hematologic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.

Descriptor ID	D019337
MeSH Number(s)	C04.588.448 C15.378.400
Concept/Terms	Hematologic Neoplasms Hematologic Neoplasms Hematologic Malignancy Neoplasms, Hematologic Hematologic Neoplasm Neoplasm, Hematologic Hematological Neoplasms Hematological Neoplasm Neoplasm, Hematological Neoplasms, Hematological Malignancies, Hematologic Malignancy, Hematologic Hematologic Malignancies Hematological Malignancies Hematological Malignancy Malignancies, Hematological Malignancy, Hematological Hematopoietic Neoplasms Hematopoietic Neoplasms Neoplasms, Hematopoietic Hematopoietic Neoplasm Neoplasm, Hematopoietic Hematopoietic Malignancies Hematopoietic Malignancy Malignancies, Hematopoietic Malignancy, Hematopoietic

Below are MeSH descriptors whose meaning is more general than "Hematologic Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Hematologic Neoplasms".

Hematologic Neoplasms
Bone Marrow Neoplasms

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hematologic Neoplasms" by people in this website by year, and whether "Hematologic Neoplasms" was a major or minor topic of these publications.

Bar chart showing 62 publications over 27 distinct years, with a maximum of 6 publications in 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	2	0	2
1997	0	1	1
2000	1	1	2
2001	0	2	2
2002	1	0	1
2003	1	0	1
2004	1	0	1
2005	2	3	5
2006	0	2	2
2007	5	0	5
2008	1	1	2
2009	1	1	2
2010	2	0	2
2011	1	0	1
2012	4	0	4
2013	1	1	2
2014	1	1	2
2015	5	0	5
2016	2	0	2
2017	3	0	3
2019	1	0	1
2020	2	0	2
2021	1	1	2
2022	2	0	2
2023	6	0	6
2024	1	0	1
2025	1	0	1

Below are the most recent publications written about "Hematologic Neoplasms" by people in Profiles.

Doolub G, Raichman A, Abramov D, Bang V, Parwani P, Karunanithi K, Abdel-Qadir H, Kobo O, Mamas MA. Temporal trends in cardiovascular mortality among patients with hematological malignancies: a 20-year perspective. Expert Rev Cardiovasc Ther. 2025 Jan-Feb; 23(1-2):35-43.

View in: PubMed
Guido O, Lubwama M, Kiconco P, Okeng A, Najjingo I, Aboce E, Phiona R, Nabbanja H, Ndagire M, Eva K, Enock W, Orem J, Joloba ML, Bwanga F. Human cytomegalovirus infection among febrile hematological cancer patients at the Uganda Cancer Institute. Microbiol Spectr. 2024 Nov 05; 12(11):e0048124.

View in: PubMed
Sahin Y, Wang YL, Pei J, Mansoor N, Styler M, Testa JR, Nejati R. Multiple Genomic Alterations, Including a Novel AFF4::IRF1 Fusion Gene, in a Treatment-Refractory Blastic Plasmacytoid Dendritic-Cell Neoplasm: A Case Report and Literature Review. Int J Mol Sci. 2023 Dec 25; 25(1).

View in: PubMed
Sun G, Weiss A, Zhao J, Silver M, DeMaio M, Dehbashi S. Isolated cerebral Mucormycosis and Aspergillosis coinfection in an immunocompromised adult. BMJ Case Rep. 2023 Aug 27; 16(8).

View in: PubMed
Quagliano A, Gopalakrishnapillai A, Barwe SP. Tetraspanins set the stage for bone marrow microenvironment-induced chemoprotection in hematologic malignancies. Blood Adv. 2023 08 22; 7(16):4403-4413.

View in: PubMed
Bola?os-Meade J, Hamadani M, Wu J, Al Malki MM, Martens MJ, Runaas L, Elmariah H, Rezvani AR, Gooptu M, Larkin KT, Shaffer BC, El Jurdi N, Loren AW, Solh M, Hall AC, Alousi AM, Jamy OH, Perales MA, Yao JM, Applegate K, Bhatt AS, Kean LS, Efebera YA, Reshef R, Clark W, DiFronzo NL, Leifer E, Horowitz MM, Jones RJ, Holtan SG. Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis. N Engl J Med. 2023 Jun 22; 388(25):2338-2348.

View in: PubMed
Nguyen J, Maio V, Walsh K, Handley N, Patel S, Keith SW, Csik VP. Hematologic Malignancy Episodes Exceed Target Price in Oncology Care Model. Am J Med Qual. 2023 Jul-Aug 01; 38(4):174-180.

View in: PubMed
Sindaco P, Pandey H, Isabelle C, Chakravarti N, Brammer JE, Porcu P, Mishra A. The role of interleukin-15 in the development and treatment of hematological malignancies. Front Immunol. 2023; 14:1141208.

View in: PubMed
Yang Y, Bi X, Gergis M, Yi D, Hsu J, Gergis U. Allogeneic Chimeric Antigen Receptor T Cells for Hematologic Malignancies. Hematol Oncol Stem Cell Ther. 2022 Dec 15; 15(3):112-116.

View in: PubMed
Bi X, Gergis U, Wagner JL, Carabasi M, Filicko-O'Hara J, O'Hara W, Klumpp T, Porcu P, Flomenberg N, Grosso D. Outcomes of two-step haploidentical allogeneic stem cell transplantation in elderly patients with hematologic malignancies. Bone Marrow Transplant. 2022 11; 57(11):1671-1680.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement